Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00667511 · ClinicalTrials.gov registry record · NA
Comparison of Nocturnal Hemodialysis (NHD) and Short Daily Hemodialysis (DHD) With the NxStage® System One™
A NA study of End Stage Renal Disease and Kidney Failure, Chronic, sponsored by NxStage Medical.
- Completed
- Registry status
- NA
- Development phase
- 58
- Enrollment target
- 9
- Study locations
NCT00667511 is a NA study of End Stage Renal Disease and Kidney Failure, Chronic that has completed, run by NxStage Medical. The registered enrollment target is 58 participants, below the 833-participant average among 86 other End Stage Renal Disease trials with a reported enrollment target (93% lower). The trial reports 9 study locations across 9 states.
The verdict
NCT00667511, a NA study of End Stage Renal Disease and Kidney Failure, Chronic, has completed, sponsored by NxStage Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 58 participants
- Enrollment target
- 9
- Study locations
Study Summary
The purpose of this study is to determine whether or not nocturnal hemodialysis is equivalent to short daily hemodialysis on a per treatment basis, using the NxStage System One in the home setting.
Conditions Studied
Interventions
- DEVICE NxStage System One
Study Locations (9)
California
- Satellite Healthcare/Wellbound - San Jose
Illinois
- Circle Medical Management - Chicago
Indiana
- Indiana University Dialysis Center - Indianapolis
Kansas
- Kansas Nephrology Research Institute, LLC - Wichita
Missouri
- Barnes Jewish Dialysis Center - St Louis
Nebraska
- Dialysis Center of Lincoln - Lincoln
New York
- Rubin Dialysis - Saratoga Springs
Texas
- DaVita Grapevine at Home - Grapevine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2008-04 |
| Est. Completion | 2014-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00667511
The ClinicalTrials.gov registry entry for NCT00667511 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 58 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 833-participant average among 86 other End Stage Renal Disease trials with a reported enrollment target (93% lower). The listed sponsor is NxStage Medical, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with End Stage Renal Disease appearing as the primary indexed condition, and to 1 intervention - of which NxStage System One is the first listed.
NCT00667511 reports 9 study locations spanning 9 distinct geographic areas - top geographies include California, Illinois, Indiana.
Frequently Asked Questions
What is clinical trial NCT00667511 about?
NCT00667511 is a clinical study titled "Comparison of Nocturnal Hemodialysis (NHD) and Short Daily Hemodialysis (DHD) With the NxStage® System One™". The purpose of this study is to determine whether or not nocturnal hemodialysis is equivalent to short daily hemodialysis on a per treatment basis, using the NxStage System One in the home setting.
What is the current status of trial NCT00667511?
This trial is currently completed. It is a NA study. The enrollment target is 58 participants. The study started on 2008-04. Estimated completion is 2014-05.
What conditions does trial NCT00667511 study?
This clinical trial studies the following conditions: End Stage Renal Disease, Kidney Failure, Chronic.
What interventions are being tested in trial NCT00667511?
The interventions under investigation include: NxStage System One (DEVICE).
Who is sponsoring clinical trial NCT00667511?
This trial is sponsored by NxStage Medical, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00667511 being conducted?
This trial has 9 study locations across California, Illinois, Indiana, Kansas, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for End Stage Renal Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
RECRUITING · NA
-
Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial
RECRUITING · NA
-
Shared Decision Making for Kidney Transplant Candidates to Plan for an Organ Offer Decision
RECRUITING · NA
-
Blood Pressure Slopes and Ultrafiltration in Hemodialysis Patients
RECRUITING · NA
-
CAPABLE Transplant
RECRUITING · NA
-
Intravascular Ultrasound in Patients With End-stage Renal Disease on Dialysis
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.